Results from a phase II clinical trial, experimental work on cells and computational modelling have together shown why the first pill for asthma in 20 years can help reduce asthma attacks.

Researchers from Leicester (UK) and Vancouver (Canada) have shown that the investigational drug, Fevipiprant (an oral, selective prostaglandin D2 receptor antagonist), reduces the amount of smooth muscle in the airway lining. The findings are published in Science Translational Medicine today (13 February).

Read More

A major international study has found that rapidly lowering blood pressure safely reduces the risk of bleeding in the brain in stroke patients being treated with clot-busting drugs. The research, which was led in the UK by the University of Leicester and funded by the Stroke Association, will be published today (7 February) in The Lancet.

Read More

A project led by the University of Leicester is one of 10 projects announced to receive a share of £3 million Government funding to prove the potential of health data to transform lives.
Read More

A £2.68 million study to investigate the effective use of antibiotics to treat certain types of severe asthma is being spearheaded by researchers in Leicester.

New research published by teams from Leicester,UK and Paris, France in collaboration with international partners from the US and Australia, has found a common genetic factor that confers a significant risk of atypical heart attacks in women.

Dr Richard Allen of the University of Leicester has been awarded a Mike Bray research fellowship into the causes and treatments of idiopathic pulmonary fibrosis (IPF) from the charity, Action for Pulmonary Fibrosis.